SCG Cell Therapy Presents Promising Phase 1 Data for a Novel HBV-Specific TCR-T Therapy (SCG101) at the AASLD Liver Meeting 2024
SINGAPORE,Nov. 25,2024-- SCG Cell Therapy Pte Ltd (SCG),a clinical-stage biotechnology company focused on developing innovative immunotherapies for infectious diseases and associated cancers,announced












